Grandfield & Dodd LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 34.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 298,885 shares of the company’s stock after acquiring an additional 76,035 shares during the quarter. GE HealthCare Technologies makes up approximately 1.6% of Grandfield & Dodd LLC’s holdings, making the stock its 24th largest position. Grandfield & Dodd LLC owned 0.07% of GE HealthCare Technologies worth $23,110,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Barclays PLC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $92,462,000. Thrivent Financial for Lutherans purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $1,590,000. MML Investors Services LLC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $929,000. Schonfeld Strategic Advisors LLC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $3,474,000. Finally, Tower Research Capital LLC TRC purchased a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $1,150,000. 82.06% of the stock is owned by institutional investors.
GE HealthCare Technologies Stock Performance
GEHC traded down $0.48 during mid-day trading on Friday, reaching $84.49. 2,022,710 shares of the company traded hands, compared to its average volume of 2,568,032. The stock has a market capitalization of $38.56 billion, a P/E ratio of 27.98, a P/E/G ratio of 2.96 and a beta of 0.94. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. The company’s fifty day moving average price is $88.74 and its 200-day moving average price is $77.82. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50.
GE HealthCare Technologies Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.97%.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the stock. Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. HSBC started coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Mizuho boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, April 11th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $95.09.
View Our Latest Stock Analysis on GE HealthCare Technologies
About GE HealthCare Technologies
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 4/15 – 4/19
- What Are Dividend Champions? How to Invest in the Champions
- Comprehensive Analysis of PayPal Stock
- About the Markup Calculator
- Intuitive Surgical Stock Can Trend Much Higher This Year
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.